Statin therapy of calcific aortic stenosis: hype or hope?
Open Access
- 6 January 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (7), 773-778
- https://doi.org/10.1093/eurheartj/ehi697
Abstract
Calcific aortic stenosis, with a prevalence of 3–9%, is the most frequent heart valve disease and the main cause for valve replacement in patients over 60 years of age. Once thought to be caused by a passive calcium precipitate within the aortic valve leaflets, there is now increasing evidence that development and progression of calcific aortic valve disease may be triggered by underlying genetic and cardiovascular risk factors, and is regulated by an active cellular process involving inflammatory pathways. Targeted drug therapy to prevent the progression of calcific aortic valve disease should ideally be based on the knowledge of risk factors and the molecular pathogenesis of the disease. Conflicting data exists on the potency of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (i.e. statins) to influence both risk factors and inflammatory pathways by lowering lipid levels and exerting anti-inflammatory properties, respectively. In this review, various aspects of the molecular pathogenesis of calcific aortic stenosis will be summarized and connected with recent experimental and clinical studies that address the potential benefit of the targeted drug therapy by statins in order to prevent the progression of the disease.Keywords
This publication has 72 references indexed in Scilit:
- Mutations in NOTCH1 cause aortic valve diseaseNature, 2005
- Calcific aortic stenosis: same old story?Age and Ageing, 2004
- Hyperlipidaemia and aortic valve diseaseCurrent Opinion in Lipidology, 2004
- The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosisEuropean Heart Journal, 2004
- Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosisAtherosclerosis, 2003
- The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosisHeart, 2001
- Circulation, 1994
- Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valvesJournal of the American College of Cardiology, 1994
- Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sampleJournal of the American College of Cardiology, 1993
- Der normale histologische Bau und die Sklerose der AortenklappenVirchows Archiv, 1904